Notify me when Lombard Odier Asset Management (USA) Corp files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Silence Therapeutics plc | Ordinary Shares, par value GBP 0.05 per share (the "Shares") | 4.2% | 5,935,955 | -45% | Lombard Odier Asset Management (USA) Corp | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|